156 related articles for article (PubMed ID: 29858157)
1. Cyclic biphalin analogues with a novel linker lead to potent agonist activities at mu, delta, and kappa opioid receptors.
Remesic M; Macedonio G; Mollica A; Porreca F; Hruby V; Lee YS
Bioorg Med Chem; 2018 Jul; 26(12):3664-3667. PubMed ID: 29858157
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment.
Yang L; Islam MR; Karamyan VT; Abbruscato TJ
Brain Res; 2015 Jun; 1609():1-11. PubMed ID: 25801116
[TBL] [Abstract][Full Text] [Related]
3. Potent biphalin analogs with µ/δ mixed opioid activity: in vivo and in vitro biological evaluation.
Costante R; Pinnen F; Stefanucci A; Mollica A
Arch Pharm (Weinheim); 2014 May; 347(5):305-12. PubMed ID: 24798820
[TBL] [Abstract][Full Text] [Related]
4. Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.
Brissett DI; Whistler JL; van Rijn RM
Eur J Pain; 2012 Mar; 16(3):327-37. PubMed ID: 22337177
[TBL] [Abstract][Full Text] [Related]
5. A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA
Li G; Nieman AN; Mian MY; Zahn NM; Mikulsky BN; Poe MM; Methuku KR; Liu Y; Cook JM; Stafford DC; Arnold LA
Molecules; 2020 Aug; 25(17):. PubMed ID: 32854311
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
7. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
[TBL] [Abstract][Full Text] [Related]
8. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of the first cyclic biphalin analogues.
Mollica A; Davis P; Ma SW; Porreca F; Lai J; Hruby VJ
Bioorg Med Chem Lett; 2006 Jan; 16(2):367-72. PubMed ID: 16275086
[TBL] [Abstract][Full Text] [Related]
10. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
[TBL] [Abstract][Full Text] [Related]
11. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.
Ji RR; Zhang Q; Law PY; Low HH; Elde R; Hökfelt T
J Neurosci; 1995 Dec; 15(12):8156-66. PubMed ID: 8613750
[TBL] [Abstract][Full Text] [Related]
12. Biphalin analogs containing β(3)-homo-amino acids at the 4,4' positions: Synthesis and opioid activity profiles.
Frączak O; Lasota A; Kosson P; Leśniak A; Muchowska A; Lipkowski AW; Olma A
Peptides; 2015 Apr; 66():13-8. PubMed ID: 25708417
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
[TBL] [Abstract][Full Text] [Related]
15. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry.
Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
J Neurochem; 1997 Sep; 69(3):1236-45. PubMed ID: 9282948
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
[TBL] [Abstract][Full Text] [Related]
17. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
[TBL] [Abstract][Full Text] [Related]
18. N-methylated cyclic enkephalin analogues retain high opioid receptor binding affinity.
Weltrowska G; Berezowska I; Lemieux C; Chung NN; Wilkes BC; Schiller PW
Chem Biol Drug Des; 2010 Feb; 75(2):182-8. PubMed ID: 20028398
[TBL] [Abstract][Full Text] [Related]
19. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes.
Onali P; Dedoni S; Olianas MC
J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
